טוען...
Understanding PD-L1 Testing in Breast Cancer: A Practical Approach
BACKGROUND: Immune checkpoint inhibitors (ICI) have changed therapy strategies for cancer patients tremendously. Some approved ICI acquire testing of PD-L1 expression on tumor and/or immune cells. However, since PD-L1 testing is a comprehensive issue with various assays, antibody clones, scoring met...
שמור ב:
| הוצא לאור ב: | Breast Care (Basel) |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
S. Karger GmbH
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7650134/ https://ncbi.nlm.nih.gov/pubmed/33223991 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000510812 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|